AB1111 SUSTAINED RESPONSE TO GUSELKUMAB REGARDLESS OF BASELINE DEMOGRAPHIC, DISEASE, AND MEDICATION CHARACTERISTICS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND AN INADEQUATE RESPONSE TO TNF INHIBITORS: RESULTS FROM A PHASE 3B TRIAL
Mcinnes, I, Sewerin, P, Sharaf, M, Efficace, M, Shawi, M, Perate, M, Zimmermann, M, Coates, L
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS1038 GUSELKUMAB EFFICACY IN PSORIATIC ARTHRITIS ASSESSED BY MULTI-DOMAIN COMPOSITE INDICES: DATA FROM THE PHASE 3B COSMOS TRIAL IN A TNFi-IR POPULATION
Gossec, L., Theander, E., Neuhold, M., Bergmans, P., Shawi, M., Perate, M., Contre, C., Coates, L.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS1043 STRONG CORRELATION BETWEEN SHORT- VS LONG-FORM COMPOSITE MEASURES OF PSORIATIC ARTHRITIS DISEASE ACTIVITY IN A TNFi-IR POPULATION TREATED WITH GUSELKUMAB: DATA FROM THE PHASE 3b COSMOS TRIAL
Tillett, W., Coates, L., Neuhold, M., Theander, E., Bergmans, P., Shawi, M., Perate, M., Contre, C., Helliwell, P.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
AB0898 Guselkumab improves dactylitis in PsA patients with inadequate response to TNFi: data from the Phase 3b COSMOS trial
Marzo-Ortega, H., Theander, E., Neuhold, M., Bergmans, P., Shawi, M., Perate, M., Contre, C., Mcinnes, I., Schett, G.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
AB1122 GUSELKUMAB VS GOLIMUMAB IN PSA TNFI-INADEQUATE RESPONDERS (EVOLUTION): FORMULATING A PRAGMATIC PHASE 3B RANDOMIZED TRIAL
Ogdie, A, Reddy, S, Bush, K, S Hopkins Gillespie, Husni, M E, Karmacharya, P, Scher, J, Perate, M, Chakravarty, S D, Gong, C, Walsh, J A
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS0228 MINIMAL IMPORTANT DIFFERENCE (MID), MINIMAL DETECTABLE CHANGE (MDC), AND DISEASE ACTIVITY THRESHOLDS FOR TWO NOVEL COMPOSITE INSTRUMENTS (3VAS, 4VAS) IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED ANALYSIS OF THREE PHASE 3 STUDIES
Tillett, W, Coates, L, Vis, M, Merola, J F, Soriano, E, Perate, M, Shawi, M, Zimmermann, M, Rampakakis, E, Sharaf, M, Nash, P, Helliwell, P
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
OP0259 MINIMAL DISEASE ACTIVITY RESPONSE PATTERNS IN BIO-NAIVE PATIENTS TREATED WITH GUSELKUMAB: A MACHINE LEARNING ANALYSIS
Zabotti, A., Ohrndorf, S., Tillett, W., Neuhold, M., van Speybroeck, M., Theander, E., Contre, C., Sharaf, M., Shawi, M., Perate, M., Kollmeier, A., Richette, P.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
Pain Management in Trauma in the Age of the Opioid Crisis
Gross, Jessica Lynn, Perate, Alison R, Elkassabany, Nabil M
Published in Anesthesiology clinics (01.03.2019)
Published in Anesthesiology clinics (01.03.2019)
Get more information
Journal Article